Laurence Marton serves as Executive at RenovoRx, Inc., where they oversee executive responsibilities. Since joining the company, Laurence Marton has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 26, 2024 involved purchasing 8,196 shares valued at $0.
Laurence Marton currently holds 33,634 shares of RenovoRx, Inc. (RNXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laurence Marton has been a net neutral trader of RNXT stock. They have purchased $0 and sold $0 worth of shares.
Laurence Marton's most recent insider trade was on Jan 26, 2024, when they purchased 8,196 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.70 |
| Discretionary |